Proposed 30,000-share option exercise by MAZE (NASDAQ: MAZE) reported

Rhea-AI Filing Summary

MAZE: Notice of proposed sale of 30,000 common shares via option exercise. The filing lists 30,000 shares to be sold on 03/30/2026 through the exercise of stock options for cash. The record shows two prior 10b5-1 sales by Atul Dandekar: 7,500 shares on 02/27/2026 for $340,722.75 and 7,500 shares on 01/29/2026 for $331,990.50. The filing references 49,708,658 shares outstanding as of 03/30/2026.

Insights

Corporate Finance Analyst

Routine Form 144: option exercise and prior 10b5-1 sales reported; no new material corporate action.

The notice reports a proposed sale of 30,000 shares via exercise of employee stock options on 03/30/2026, a common liquidity event for insiders exercising compensation. Two prior scheduled 10b5-1 sales of 7,500 shares each occurred on 01/29/2026 and 02/27/2026.

Cash proceeds are indicated for the exercise; cash‑flow treatment and purchaser details are not provided in the excerpt. Subsequent filings or trade reports will show completed transactions and any impact on outstanding float of 49,708,658 shares as of 03/30/2026.

Key Figures

Shares proposed to be sold: 30,000 shares Proceeds shown (line item): $911,400.00 Shares outstanding: 49,708,658 shares +2 more

5 metrics

Shares proposed to be sold 30,000 shares to be sold via exercise of stock options on 03/30/2026

Proceeds shown (line item) $911,400.00 amount listed alongside the 30,000-share line (03/30/2026)

Shares outstanding 49,708,658 shares as of 03/30/2026

10b5-1 sale on 02/27/2026 7,500 shares sold for $340,722.75 by Atul Dandekar

10b5-1 sale on 01/29/2026 7,500 shares sold for $331,990.50 by Atul Dandekar

Key Terms

10b5-1, Exercise of Stock Options, Form 144

3 terms

10b5-1 regulatory

"10b5-1 Sales for ATUL DANDEKAR 171 Oyster Point Blvd Suite 300"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Exercise of Stock Options financial

"Securities To Be Sold | Common | 03/30/2026 | Exercise of Stock Options"

Form 144 regulatory

"144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	30000	911400.00	49708658	03/30/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/30/2026	Exercise of Stock Options	Issuer			30000	03/30/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ATUL DANDEKAR 171 Oyster Point Blvd Suite 300 South San Francisco CA 94080	Common	02/27/2026	7500	340722.75
10b5-1 Sales for ATUL DANDEKAR 171 Oyster Point Blvd Suite 300 South San Francisco CA 94080	Common	01/29/2026	7500	331990.50

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does MAZE's Form 144 report?

It reports a proposed sale of 30,000 common shares via exercise of stock options on 03/30/2026. The filing also lists two prior 10b5-1 sales of 7,500 shares each in January and February 2026.

Who executed prior 10b5-1 sales disclosed in the MAZE filing?

The prior 10b5-1 sales were executed by Atul Dandekar, selling 7,500 shares on 01/29/2026 and 7,500 shares on 02/27/2026, with proceeds of $331,990.50 and $340,722.75, respectively.

How many shares outstanding does MAZE show in the filing?

The filing references 49,708,658 shares outstanding as of 03/30/2026. This figure appears alongside the proposed sale and provides a baseline for the company’s share count on that date.

Will MAZE receive proceeds from the 30,000-share transaction?

The filing indicates the securities to be sold arise from an exercise of stock options and lists Cash as the method, implying cash was involved in the exercise. The excerpt does not detail whether proceeds go to the issuer or selling holder.

Are the January and February 2026 trades part of a pre-arranged plan?

Yes. The January and February trades are described as 10b5-1 sales, which indicates they were executed under a pre-arranged trading plan. The filing lists those sales with dates and amounts.